Lantheus Medical Imaging Announces Strategic Relationship with Beijing Double-Crane Pharmaceuticals for the Distribution and Supply of DEFINITY® in China
NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced a strategic distribution arrangement for DEFINITY® Vial for (Perflutren Lipid Microsphere) Injectable Suspension in the People’s Republic of China, including Hong Kong S.A.R. and Macau S.A.R.